This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Lawmakers grilled Environmen-tal Protection Agency officials during an April 16 hearing on pharmaceutical contamination of the nation’s drinking water. The hearing before a Senate subcommittee was prompted by an Associated Press report that claimed traces of pharmaceuticals were found in the drinking water of 24 major U.S. cities. Sen. Barbara Boxer (D-Calif.) said the agency is six years behind schedule in identifying and addressing chemicals that harm human hormones, called endocrine-disrupting chemicals. She said EPA should issue a rule to require monitoring of pharmaceuticals in drinking water.
Benjamin Grumbles, EPA assistant administrator for water, said pharmaceuticals are a growing priority for EPA, “but at this point the scientific jury is still out as far as the risk to public health.”